{
    "id": "NCLEX_NGN_SA_500107",
    "itemType": "selectN",
    "question": "The nurse is reviewing the plan of care and newly entered provider orders for the client. Which actions should the nurse take at this time? Select all that apply.",
    "tabs": [
        {
            "id": "tab1",
            "title": "Nurses' Notes",
            "content": "{\n  \"Triage Note (13:00)\": \"A 68-year-old male with a history of CKD stage 4, HTN, and HFpEF presents to the ED with a 2-day history of progressive muscle weakness, fatigue, and nausea. Client states he has been taking 'some extra ibuprofen' for worsening knee pain. Reports running out of his furosemide 3 days ago but has continued his other prescribed medications. He mentions he has been unable to afford the copay for physical therapy for his knee osteoarthritis.\",\n  \"ED Nurse Note (14:30)\": \"Client is lethargic but oriented to person and place. Denies chest pain or shortness of breath. Bilateral lower extremity muscle strength is 3/5. Abdomen is soft, non-distended with hypoactive bowel sounds. Skin is cool and pale.\"\n}"
        },
        {
            "id": "tab2",
            "title": "Vital Signs",
            "content": "{\n  \"headers\": [\"Time\", \"BP\", \"HR\", \"RR\", \"Temp\", \"SpO2\"],\n  \"rows\": [\n    [\"13:00\", \"148/88\", \"88\", \"18\", \"37.1 C\", \"96% RA\"],\n    [\"14:00\", \"130/82\", \"64\", \"18\", \"37.1 C\", \"95% RA\"],\n    [\"14:30\", \"118/76\", \"52\", \"16\", \"37.0 C\", \"96% RA\"]\n  ]\n}"
        },
        {
            "id": "tab3",
            "title": "Laboratory Results",
            "content": "{\n  \"Potassium\": \"7.1 mEq/L (Critical)\",\n  \"Sodium\": \"134 mEq/L\",\n  \"BUN\": \"68 mg/dL\",\n  \"Creatinine\": \"3.9 mg/dL\",\n  \"Glucose\": \"110 mg/dL\",\n  \"Troponin I\": \"<0.01 ng/mL\"\n}"
        },
        {
            "id": "tab4",
            "title": "Diagnostics",
            "content": "{\n  \"12-Lead ECG Interpretation (14:15)\": \"Sinus bradycardia at 52 bpm. Prominent peaked T waves noted in precordial leads. PR interval prolonged (0.24 seconds). QRS complex widened (0.14 seconds). Findings are highly suggestive of severe hyperkalemia.\"\n}"
        },
        {
            "id": "tab5",
            "title": "MAR",
            "content": "{\n  \"Scheduled Medications\": [\n    {\"medication\": \"Lisinopril 10 mg PO daily\", \"status\": \"Due at 15:00\"},\n    {\"medication\": \"Spironolactone 25 mg PO daily\", \"status\": \"Due at 15:00\"}\n  ],\n  \"STAT Orders (Entered at 14:40)\": [\n    {\"medication\": \"Calcium Gluconate 1 g IVPB over 10 minutes\", \"status\": \"New\"},\n    {\"medication\": \"Regular Insulin 10 units IV push\", \"status\": \"New\"},\n    {\"medication\": \"Dextrose 50% 25 g IV push\", \"status\": \"New\"},\n    {\"medication\": \"Sodium Polystyrene Sulfonate 15 g PO\", \"status\": \"New\"}\n  ]\n}"
        }
    ],
    "options": [
        {
            "id": "opt5",
            "text": "Administer the scheduled lisinopril to address the client's history of hypertension."
        },
        {
            "id": "opt1",
            "text": "Administer calcium gluconate 1 g IVPB immediately."
        },
        {
            "id": "opt4",
            "text": "Place the client on a continuous cardiac monitor."
        },
        {
            "id": "opt3",
            "text": "Administer the regular insulin and dextrose as prescribed."
        },
        {
            "id": "opt6",
            "text": "Request a repeat potassium level in 6 hours to evaluate treatment effectiveness."
        },
        {
            "id": "opt2",
            "text": "Withhold the scheduled 15:00 dose of spironolactone."
        }
    ],
    "correct": [
        "opt1",
        "opt2",
        "opt3",
        "opt4"
    ],
    "answerBreakdown": {
        "opt1": {
            "isCorrect": true,
            "rationale": "Correct. The client's ECG shows significant signs of cardiac toxicity from hyperkalemia (bradycardia, peaked T waves, prolonged PR, widened QRS). Calcium gluconate is the first-line, emergent treatment to stabilize the cardiac membrane and prevent life-threatening dysrhythmias like ventricular fibrillation or asystole. This is the highest priority medication to administer."
        },
        "opt2": {
            "isCorrect": true,
            "rationale": "Correct. This is a critical 'SAFETY STOP' action. Spironolactone is a potassium-sparing diuretic. Administering this medication to a client with a potassium level of 7.1 mEq/L would be a severe medication error, worsening the life-threatening hyperkalemia. The nurse must recognize this contraindication and withhold the medication, then notify the provider."
        },
        "opt3": {
            "isCorrect": true,
            "rationale": "Correct. After stabilizing the cardiac membrane with calcium, the next priority is to lower the serum potassium level. IV regular insulin works quickly to shift potassium from the extracellular fluid into the intracellular space. Dextrose is administered concurrently to prevent hypoglycemia, as the client's baseline glucose is normal."
        },
        "opt4": {
            "isCorrect": true,
            "rationale": "Correct. Given the critical potassium level and significant ECG changes, the client is at high risk for sudden, lethal cardiac arrhythmias. Continuous cardiac monitoring is an essential, independent nursing action to ensure immediate detection of and response to any deterioration in cardiac rhythm."
        },
        "opt5": {
            "isCorrect": false,
            "rationale": "Incorrect. Lisinopril is an ACE inhibitor, which is known to cause hyperkalemia by decreasing aldosterone secretion. Administering this medication would exacerbate the client's condition. It is contraindicated in cases of acute kidney injury and severe hyperkalemia. The nurse must withhold this medication and clarify the order with the provider."
        },
        "opt6": {
            "isCorrect": false,
            "rationale": "Incorrect. While a repeat potassium level is necessary, waiting 6 hours is unsafe and inappropriate. The client's response to emergent treatment (insulin, dextrose, calcium) should be evaluated much sooner, typically within 1 hour after the interventions, to determine if further action is needed."
        }
    }
}